This article is a retraction of:
RETRACTED: LncRNA TCF7 Promotes Epithelial Ovarian Cancer Viability, Mobility and Stemness via Regulating ITGB8
A Retraction of the Original Research Article
LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8
by Su C and Huang K (2021) Front. Oncol. 11:649655. doi: 10.3389/fonc.2021.649655
The Publisher retracts the cited article.
Following publication, the publisher has discovered that the authors provided false information for the peer-review process. As the scientific integrity of the article cannot be guaranteed, and adhering to the recommendations of the Committee on Publication Ethics (COPE), the publisher therefore retracts the article.
The authors have not responded to this retraction.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.
Citation: Frontiers Editorial Office (2023) Retraction: LncRNA TCF7 promotes epithelial ovarian cancer viability, mobility and stemness via regulating ITGB8. Front. Oncol. 13:1307324. doi: 10.3389/fonc.2023.1307324
Received: 04 October 2023; Accepted: 04 October 2023;
Published: 19 October 2023.
Approved by:
Sophia George, University of Miami, United StatesCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org